Digene Announces Investor Community Day Webcast on Tuesday, June 5, 2007
June 01 2007 - 8:00AM
PR Newswire (US)
GAITHERSBURG, Md., June 1 /PRNewswire-FirstCall/ -- Digene
Corporation (NASDAQ:DIGE), today announced that the Company will
webcast audio from presentations at the Company's Investment
Community Day on Tuesday, June 5, 2007. The event will be held from
8:30 a.m. to 12:30 p.m. EDT. The event will feature presentations
from Digene's senior management team, as well as guest speakers
from Columbia University and University Hospital Vrije
Universiteit, Amsterdam, The Netherlands. The Analyst and Investor
Day will be webcast live and may be accessed through a link on
Digene's website at http://www.digene.com/. An archive of the
presentation will be available on Digene's website until August 5,
2007. About Digene A leader in molecular diagnostics, Digene
develops, manufactures and markets proprietary DNA and RNA tests,
with a focus on women's health. The company's flagship product, the
Digene(R) HPV Test, is the only FDA-approved and CE-marked test for
the detection of human papillomavirus, the cause of essentially all
cervical cancers. Digene's product portfolio also includes tests
for the detection of other sexually transmitted infections,
including chlamydia and gonorrhea. Digene tests are marketed in
more than 40 countries worldwide. Headquartered in Gaithersburg,
MD, Digene is traded on NASDAQ under the symbol DIGE. For more
information, visit http://www.digene.com/ and
http://www.thehpvtest.com/. Digene(R), Hybrid Capture(R), hc2
High-Risk HPV DNA Test(R) and DNAwithPap(R) are registered
trademarks of Digene Corporation. DATASOURCE: Digene Corporation
CONTACT: Albert Fleury, +1-301-944-7000, or Media, Pam Rasmussen,
+1-301-944-7196, both of Digene Corporation Web site:
http://www.digene.com/ http://www.thehpvtest.com/
Copyright
Digene (NASDAQ:DIGE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Digene (NASDAQ:DIGE)
Historical Stock Chart
From Jul 2023 to Jul 2024